|
|
||||||||
Ann Thorac Surg 2002;73:1026-1027
© 2002 The Society of Thoracic Surgeons
a Clinic for Cardiovascular Surgery, University Hospital, 24 rue Micheli-du-Crest, CH-1211 Geneva 24, Switzerland
b Division of Cardiology, MS-119, Hahnemann University Hospital, Broad and Vine Sts, Philadelphia, PA 19102, USA
e-mail: jtchristenson{at}hotmail.com
e-mail: marc.cohen{at}tenethealth.com
To the Editor
In an article by Davies and associates, recently published in The Annals [1], it was reported, from a retrospective analysis of 39 patients requiring intraaortic balloon pump (IABP) support after cardiac surgery, and employing univariate analysis, that persistent high lactate predicts failure of intraaortic balloon pumping. However, cardioplegic arrest induces anaerobic myocardial metabolism which leads to a net production of lactate from glycolysis, and persistant lactate is an independent predictor of postoperative low cardiac output due to a delayed recovery of aerobic myocardial metabolism [2]. To overcome postoperative low cardiac output inotrope support, often IABP is required. Since delay in recovery of aerobic myocardial metabolism has nothing to do with IABP per se, we have some difficulties in understanding this relationship claimed by the authors.
Preoperative IABP therapy in high-risk patients alleviates myocardial ischemia prior to circulatory arrest and paves the way for quick postoperative recovery to normal metabolism and less lactate formation [34]. It was therefore interesting to notice in Davies and coworkers article that 7 of 10 patients who received preoperative IABP survived compared to 37% when IABP was initiated intra- or postoperative. These results do correspond better with the more modern literature on IABP therapy [56]. The authors have not separated out pre-, intra-, and postoperative balloon insertions to derive their conclusion. They refer to very old literature when they discuss their very high complication rates [1]. Overall IABP-related complications in 1,119 patients treated with IABP was reported to be 15%, and major complications occurred in only 4.1% [7]. The authors should restate their conclusion as "preoperative IABP in high-risk patients reduces postoperative lactate release and subsequent mortality."
References
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |